Minutes - TRIPS Council - View details of the intervention/statement

Ambassador Eduardo Pérez Motta (Mexico)
C.i Scope and coverage
36. The representative of Ecuador said that the flexibility in Articles 7 and 8 of the TRIPS Agreement was the sort needed to find an appropriate solution under paragraph 6. No country was immune to public health problems of great severity, so there was no good reason to restrict the solution under the Declaration to any particular set of countries. Least-developed countries and developing countries should, however, be the major beneficiaries of the solution and every country should be able to decide whether to take advantage of the solution or not. Ecuador, and many other developing countries, lacked manufacturing capacity and a solution should extend to all such developing countries. Coverage should include a broad range and not be restricted only to pharmaceutical products as each country should have the flexibility to decide how to deal with public health problems. As to the source of such products, the country that lacked manufacturing capacity should be able to decide which country to approach. All countries with sufficient manufacturing capacity able to help countries with serious health problems should do so. With respect to the Doha Declaration only the country involved could decide how serious the situation was and there should be no limitation as to the diseases or epidemics being addressed under the solution.